L. F. Shamuratova
Research Subjects
L. F. Shamuratova has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- T. A. Sevostyanova
Moscow Municipal Scientific Practical Center of Tuberculosis Control
7 shared publications - Elena M. Bogorodskaya
Central Research Institute of Tuberculosis; Russian Medical Academy of Continuous Professional Education
5 shared publications - Liudmila V. Slogotskaya
Moscow Research and Clinical Center for Tuberculosis Control of the Moscow Government Department of Health; Russian Medical Academy of On-going Professional Education, Russian Ministry of Health
5 shared publications - Dmitry Anatolievich Kudlay
Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119435 Moscow, Russia
2 shared publications - Alexey I. Mazus
Moscow City Center for AIDS Prevention and Control
1 shared publication - E. M. Serebryakov
Moscow City Center for AIDS Prevention and Control
1 shared publication
Latest Publications
- Open Access
- 2 August 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 134-142
Features of the methodology for calculating the tuberculosis screening coverage rate for children in a megalopolis
Introduction. The paediatric tuberculosis screening coverage rate can vary significantly depending on its calculation and planning methodology, which will ultimately affect the formation of rates in the reporting period.Aim. To review the results of annual immunological screening and the methodology for calculating the preventive tuberculosis screening coverage rates for the metropolitan population aged 1–17 years.Materials and methods. The data from 2023 healthcare facility reports on preventive screening of children aged 1–17 years in Moscow using a skin test with purified tuberculosis allergen-standard solution and a skin test using recombinant tuberculosis allergen-standard solution were used.Results. In accordance with the 2023 population screening program for early detection of tuberculosis in Moscow, the number of children screened for tuberculosis using immunoassay tests amounted to 1,900,739 (96.4% coverage of the assigned population). According to the data of Federal Statistical Monitoring (FSN) Form No. 30, 1,921,590 children (including 718,272 children aged 1–7 years) were screened for early detection of tuberculosis in Moscow healthcare facilities in 2023 (97.5% coverage rate against the program target), and 1,916,255 children were screened in healthcare facilities with assigned population (97.2% coverage rate against the program target). The preventive pediatric tuberculosis screening made it possible to identify 45 new cases of tuberculosis among children and adolescents, 86 new cases of residual post-tuberculosis changes, and also to form a high-risk group among children with altered tuberculosis allergen sensitivity (3,772).Conclusions. The paediatric tuberculosis screening coverage rate depends on its calculation methodology; it should be planned and calculated based on the number of the assigned population to be served by healthcare facilities.
- 2 August 2025
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 11,p. 134-142
Open AccessFeatures of the methodology for calculating the tuberculosis screening coverage rate for children in a megalopolis
Introduction. The paediatric tuberculosis screening coverage rate can vary significantly depending on its calculation and planning methodology, which will ultimately affect the formation of rates in the reporting period.Aim. To review the results of annual immunological screening and the methodology for calculating the preventive tuberculosis screening coverage rates for the metropolitan population aged 1–17 years.Materials and methods. The data from 2023 healthcare facility reports on preventive screening of children aged 1–17 years in Moscow using a skin test with purified tuberculosis allergen-standard solution and a skin test using recombinant tuberculosis allergen-standard solution were used.Results. In accordance with the 2023 population screening program for early detection of tuberculosis in Moscow, the number of children screened for tuberculosis using immunoassay tests amounted to 1,900,739 (96.4% coverage of the assigned population). According to the data of Federal Statistical Monitoring (FSN) Form No. 30, 1,921,590 children (including 718,272 children aged 1–7 years) were screened for early detection of tuberculosis in Moscow healthcare facilities in 2023 (97.5% coverage rate against the program target), and 1,916,255 children were screened in healthcare facilities with assigned population (97.2% coverage rate against the program target). The preventive pediatric tuberculosis screening made it possible to identify 45 new cases of tuberculosis among children and adolescents, 86 new cases of residual post-tuberculosis changes, and also to form a high-risk group among children with altered tuberculosis allergen sensitivity (3,772).Conclusions. The paediatric tuberculosis screening coverage rate depends on its calculation methodology; it should be planned and calculated based on the number of the assigned population to be served by healthcare facilities.
- Open Access
- 16 December 2024
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 102 (6) , 20-30
Specific Manifestations of Tuberculosis Infection in Different Age Groups in Children and Adolescents according to Results of Screening with 2 Intradermal Tests (with Tuberculin and Tuberculous Recombinant Allergen (CFP10-ESAT6)) in Moscow in 2023
The objective: to assess effectiveness of mass screening for tuberculosis infection in children and adolescents in Moscow, determine infection rate and incidence in different age groups.Subjects and Methods. Screening was performed in 2023. Two different screening methods were used in different ages: all children aged 0 to 7 years were given Mantoux test with 2 TU PPD-L, and if the reaction increased versus the previous year, a test with tuberculous recombinant allergen (Diaskintest or TRA) was performed additionally. Children and adolescents aged 8-17 years were given the TRA test only. Mantoux test was used in 729,972 children from 0 to 7 years old. Positive responses were observed in 488,706 (66.9%) of them, which was due to the high rate of post-vaccination allergies at that age. When tuberculosis infection was suspected, the TRA test was performed in 21,552 people. (4.4% of all tuberculin-positive individuals). At the same time, positive reactions were noted in 201 people (0.9%). Among them, tuberculosis was detected in 7.5% (15 patients), post-tuberculosis changes (the calcification phase of the disease) were detected in 8.5% (17 people), while the proportion of positive reactions to the TRA test increased. Children of 8-17 years old were screened with the TRA test only. 1,170,461 people were examined, positive reactions were noted in 0.2%. The detection rate of tuberculosis among them was 1.6% (30 people), and the rate of the calcification phase of the disease indicating spontaneous recovery was 3.7%. The proportion of positive reactions is growing as the age of children increases, which corresponds to the higher incidence of pulmonary tuberculosis at these ages. The analysis of the incidence of various forms of tuberculosis in Moscow revealed the following. At the age of up to 7 years, tuberculosis of the lymphatic system predominates and this is the period with the highest incidence of this form. Then in the period before puberty, the lowest incidence is observed. After that, pulmonary forms of tuberculosis begin to predominate, and in adolescence, the incidence rises to maximum rates. BCG vaccination in the neonatal period resulted in the near disappearance of tuberculosis mortality, and such forms as miliary tuberculosis and meningitis. However, BCG vaccination and revaccination could not prevent pulmonary forms of tuberculosis in adolescence. The article presents age-specific mortality rates in Moscow in the pre-antibacterial era, when BCG vaccination was not available and the predominant forms of tuberculosis at different ages were the cause of death.Results: Obviously, a one-stage screening (TRA test) performed in children of 8-17 years old, is more convenient for both medical workers and patients, and it is more cost effective. However, it is currently impossible to switch to this test when examining children under 7 years, since children receive BCG revaccination if the response to Mantoux test is negative.
- 16 December 2024
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 102 (6) , 20-30
Open AccessSpecific Manifestations of Tuberculosis Infection in Different Age Groups in Children and Adolescents according to Results of Screening with 2 Intradermal Tests (with Tuberculin and Tuberculous Recombinant Allergen (CFP10-ESAT6)) in Moscow in 2023
The objective: to assess effectiveness of mass screening for tuberculosis infection in children and adolescents in Moscow, determine infection rate and incidence in different age groups.Subjects and Methods. Screening was performed in 2023. Two different screening methods were used in different ages: all children aged 0 to 7 years were given Mantoux test with 2 TU PPD-L, and if the reaction increased versus the previous year, a test with tuberculous recombinant allergen (Diaskintest or TRA) was performed additionally. Children and adolescents aged 8-17 years were given the TRA test only. Mantoux test was used in 729,972 children from 0 to 7 years old. Positive responses were observed in 488,706 (66.9%) of them, which was due to the high rate of post-vaccination allergies at that age. When tuberculosis infection was suspected, the TRA test was performed in 21,552 people. (4.4% of all tuberculin-positive individuals). At the same time, positive reactions were noted in 201 people (0.9%). Among them, tuberculosis was detected in 7.5% (15 patients), post-tuberculosis changes (the calcification phase of the disease) were detected in 8.5% (17 people), while the proportion of positive reactions to the TRA test increased. Children of 8-17 years old were screened with the TRA test only. 1,170,461 people were examined, positive reactions were noted in 0.2%. The detection rate of tuberculosis among them was 1.6% (30 people), and the rate of the calcification phase of the disease indicating spontaneous recovery was 3.7%. The proportion of positive reactions is growing as the age of children increases, which corresponds to the higher incidence of pulmonary tuberculosis at these ages. The analysis of the incidence of various forms of tuberculosis in Moscow revealed the following. At the age of up to 7 years, tuberculosis of the lymphatic system predominates and this is the period with the highest incidence of this form. Then in the period before puberty, the lowest incidence is observed. After that, pulmonary forms of tuberculosis begin to predominate, and in adolescence, the incidence rises to maximum rates. BCG vaccination in the neonatal period resulted in the near disappearance of tuberculosis mortality, and such forms as miliary tuberculosis and meningitis. However, BCG vaccination and revaccination could not prevent pulmonary forms of tuberculosis in adolescence. The article presents age-specific mortality rates in Moscow in the pre-antibacterial era, when BCG vaccination was not available and the predominant forms of tuberculosis at different ages were the cause of death.Results: Obviously, a one-stage screening (TRA test) performed in children of 8-17 years old, is more convenient for both medical workers and patients, and it is more cost effective. However, it is currently impossible to switch to this test when examining children under 7 years, since children receive BCG revaccination if the response to Mantoux test is negative.
- Open Access
- 17 January 2023
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 4,p. 58-62
A screening study of latent tuberculosis infection in children in a metropolis city
Objective. To carry out a screening study among children and adolescents for tuberculosis infection in the city of Moscow using modern immunodiagnostic methods.Materials and methods. The results of a mass screening study for tuberculosis prevalence in the pediatric population of a metropolis city were analyzed. The study was conducted during 2019–2021 in Moscow using the Mantoux skin test with 2 TE PPD-L and a skin test with a recombinant tuberculosis allergen (RTA), as well as the indicators of tuberculosis incidence in children.Results. The introduction of mass screening for tuberculosis based on RTA among the pediatric population and subsequent work with the identified risk groups contributed to a decrease in the number of newly-diagnosed cases. In 2019–2021, the incidence of tuberculosis among children in Moscow did not exceed 3.8 per 100 thousand children aged 0–17 years, with this number varying from 1.2 to 2.1 among permanent residents. The risk indicators of primary infection among children aged 1–7 according to the Mantoux test (0.37% in 2019, 0.47%, in 2020, and 0.35% in 2021) and the prevalence of latent tuberculosis according to the results of screening based on RTA among children aged 8–17 in 2019–2021 (no more than 0.3%) indicate a stable epidemiological situation as regards tuberculosis infection in the city.Conclusions. The development of an effective monitoring system for preventive tuberculosis screening among urban pediatric populations contributed to the detection of latent tuberculosis cases prior to the development of its local forms. The subsequent implementation of preventive measures in risk groups allowed the incidence of tuberculosis among children to be reduced.
- 17 January 2023
- Published by Pacific State Medical University in Pacific Medical Journal
- No. 4,p. 58-62
Open AccessA screening study of latent tuberculosis infection in children in a metropolis city
Objective. To carry out a screening study among children and adolescents for tuberculosis infection in the city of Moscow using modern immunodiagnostic methods.Materials and methods. The results of a mass screening study for tuberculosis prevalence in the pediatric population of a metropolis city were analyzed. The study was conducted during 2019–2021 in Moscow using the Mantoux skin test with 2 TE PPD-L and a skin test with a recombinant tuberculosis allergen (RTA), as well as the indicators of tuberculosis incidence in children.Results. The introduction of mass screening for tuberculosis based on RTA among the pediatric population and subsequent work with the identified risk groups contributed to a decrease in the number of newly-diagnosed cases. In 2019–2021, the incidence of tuberculosis among children in Moscow did not exceed 3.8 per 100 thousand children aged 0–17 years, with this number varying from 1.2 to 2.1 among permanent residents. The risk indicators of primary infection among children aged 1–7 according to the Mantoux test (0.37% in 2019, 0.47%, in 2020, and 0.35% in 2021) and the prevalence of latent tuberculosis according to the results of screening based on RTA among children aged 8–17 in 2019–2021 (no more than 0.3%) indicate a stable epidemiological situation as regards tuberculosis infection in the city.Conclusions. The development of an effective monitoring system for preventive tuberculosis screening among urban pediatric populations contributed to the detection of latent tuberculosis cases prior to the development of its local forms. The subsequent implementation of preventive measures in risk groups allowed the incidence of tuberculosis among children to be reduced.
- Open Access
- 9 December 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (11) , 29-38
Screening for tuberculosis infection in children and adolescents by two intracutaneous tests: with tuberculin and tuberculosis recombinant allergen (ESAT-6/CFP-10) in Moscow in 2021
The objective: to evaluate effectiveness of mass screening for tuberculosis infection in children and adolescents in Moscow using two different options according to age; to determine impact of the COVID-19 pandemic on effectiveness of screening campaign judging by incidence rates in children and adolescents.Subjects and Methods. In 2021, 758,634 children aged 0-7 years, or 99.2% of those to be screened, were screened using the Mantoux test. Should the reaction increase compared to the previous year, an additional test with the tuberculosis recombinant allergen (TRA) was performed. Children of 8-17 years old were screened only with TRA test. 1,070,961 people were examined, or 97.9% of those to be examined.Results. It has been demonstrated that the test with TRA can be used as a screening tool and effectively identify patients with a high risk of tuberculosis development. The preventive therapy received by those positively responding to TRA test resulted in almost no disease in them. The predominance of new cases with post-tuberculosis changes over new cases of active tuberculosis while the number of both is decreasing indicates the ability of the methods (TRA together with computed tomography) to detect minor forms of the active disease and post-tuberculous changes. In 2021 versus 2020, the number of children diagnosed with tuberculosis did not statistically significantly increase because of those who failed to be detected in 2020 due to incomplete coverage with screening related to spread of COVID-19. However, in 2021 the rates were lower than in 2019 which confirmed their positive change.Conclusion: Screening with TRA test is effective, easy to perform and can be used in primary health care.
- 9 December 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 100 (11) , 29-38
Open AccessScreening for tuberculosis infection in children and adolescents by two intracutaneous tests: with tuberculin and tuberculosis recombinant allergen (ESAT-6/CFP-10) in Moscow in 2021
The objective: to evaluate effectiveness of mass screening for tuberculosis infection in children and adolescents in Moscow using two different options according to age; to determine impact of the COVID-19 pandemic on effectiveness of screening campaign judging by incidence rates in children and adolescents.Subjects and Methods. In 2021, 758,634 children aged 0-7 years, or 99.2% of those to be screened, were screened using the Mantoux test. Should the reaction increase compared to the previous year, an additional test with the tuberculosis recombinant allergen (TRA) was performed. Children of 8-17 years old were screened only with TRA test. 1,070,961 people were examined, or 97.9% of those to be examined.Results. It has been demonstrated that the test with TRA can be used as a screening tool and effectively identify patients with a high risk of tuberculosis development. The preventive therapy received by those positively responding to TRA test resulted in almost no disease in them. The predominance of new cases with post-tuberculosis changes over new cases of active tuberculosis while the number of both is decreasing indicates the ability of the methods (TRA together with computed tomography) to detect minor forms of the active disease and post-tuberculous changes. In 2021 versus 2020, the number of children diagnosed with tuberculosis did not statistically significantly increase because of those who failed to be detected in 2020 due to incomplete coverage with screening related to spread of COVID-19. However, in 2021 the rates were lower than in 2019 which confirmed their positive change.Conclusion: Screening with TRA test is effective, easy to perform and can be used in primary health care.
- Open Access
- 12 January 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 99 (12) , 14-21
Evaluation of effectiveness of mass screening for tuberculosis infection in children from 1 to 7 years old in Moscow
The objective: to evaluate effectiveness of mass screening for tuberculosis infection in children aged 1 to 7 years in different periods – before and after the use of tuberculosis recombinant allergen skin test (TRA) in primary health care as an additional diagnostic method.Subjects and Methods. The study was designed as continuous observational prospective-retrospective study. Two different periods were assessed: the first one was 2014-2016 when screening for tuberculosis infection was performed in all children from 1 to 17 years (inclusive) using Mantoux test with 2 TU PPD-L in pediatric primary health care, and then children suspected to have a positive reaction were referred to TB dispensary where they were examined with a skin test with TRA if necessary. The second period was from 2018 to 2020 when children of 1-7 years old were given Mantoux test and if tuberculosis infection was suspected, a skin test with TRA was done both in primary health care network and TB units. In the first 3 years, 1,864,137 children were examined and in the second 3 years, 2,078,800 children from 1 to 7 years old were examined.Results. Among children of 1-7 years old who were screened by two stages (initial Mantoux test, and then in those who had a positive reaction, the TRA test was used), only 10-12% of those referred to a phthisiologist were subject to dispensary follow-up. Thus, with the implementation of the new edict on screening for tuberculosis infection in children with two tests, this proportion has not changed compared to previous years, when screening was carried out only with one Mantoux test. The reason why almost 90% of the children who were referred to TB Dispensary were not subject to dispensary follow-up is the following: children who have had previous conversion of tuberculin tests, along with everyone else are again screened with Mantoux test despite being previously followed up by TB dispensary due to the primary infection.Recommendations: Currently, there is no division of Group VI into Subgroups A, B, C in the dispensary follow up grouping. Why should conversion of Mantoux test reaction from negative into positive not be considered an infection, and the increase in the reaction must be at least 6 mm. Since Order No. 124n of the Russian Ministry of Health allows testing with TRA in the primary health care in case of suspected infection, it is advisable to refer those who have already had this test to a phthisiologist. A child with conversion of Mantoux test should not be re-screened with Mantoux test but the TRA test should be used. If a positive reaction to the TRA test occurs for the first time, it should be considered as conversion of this test, and in this case the child should be examined by computed tomography (CT), and preventive therapy should be prescribed. If in subsequent years the TRA reaction increases by at least 6 mm after previous preventive therapy, the child should be re-referred for CT to rule out the development of active tuberculosis.
- 12 January 2022
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 99 (12) , 14-21
Open AccessEvaluation of effectiveness of mass screening for tuberculosis infection in children from 1 to 7 years old in Moscow
The objective: to evaluate effectiveness of mass screening for tuberculosis infection in children aged 1 to 7 years in different periods – before and after the use of tuberculosis recombinant allergen skin test (TRA) in primary health care as an additional diagnostic method.Subjects and Methods. The study was designed as continuous observational prospective-retrospective study. Two different periods were assessed: the first one was 2014-2016 when screening for tuberculosis infection was performed in all children from 1 to 17 years (inclusive) using Mantoux test with 2 TU PPD-L in pediatric primary health care, and then children suspected to have a positive reaction were referred to TB dispensary where they were examined with a skin test with TRA if necessary. The second period was from 2018 to 2020 when children of 1-7 years old were given Mantoux test and if tuberculosis infection was suspected, a skin test with TRA was done both in primary health care network and TB units. In the first 3 years, 1,864,137 children were examined and in the second 3 years, 2,078,800 children from 1 to 7 years old were examined.Results. Among children of 1-7 years old who were screened by two stages (initial Mantoux test, and then in those who had a positive reaction, the TRA test was used), only 10-12% of those referred to a phthisiologist were subject to dispensary follow-up. Thus, with the implementation of the new edict on screening for tuberculosis infection in children with two tests, this proportion has not changed compared to previous years, when screening was carried out only with one Mantoux test. The reason why almost 90% of the children who were referred to TB Dispensary were not subject to dispensary follow-up is the following: children who have had previous conversion of tuberculin tests, along with everyone else are again screened with Mantoux test despite being previously followed up by TB dispensary due to the primary infection.Recommendations: Currently, there is no division of Group VI into Subgroups A, B, C in the dispensary follow up grouping. Why should conversion of Mantoux test reaction from negative into positive not be considered an infection, and the increase in the reaction must be at least 6 mm. Since Order No. 124n of the Russian Ministry of Health allows testing with TRA in the primary health care in case of suspected infection, it is advisable to refer those who have already had this test to a phthisiologist. A child with conversion of Mantoux test should not be re-screened with Mantoux test but the TRA test should be used. If a positive reaction to the TRA test occurs for the first time, it should be considered as conversion of this test, and in this case the child should be examined by computed tomography (CT), and preventive therapy should be prescribed. If in subsequent years the TRA reaction increases by at least 6 mm after previous preventive therapy, the child should be re-referred for CT to rule out the development of active tuberculosis.
- Open Access
- 10 March 2021
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 99 (2) , 21-28-28
Specific parameters for formation of the tuberculosis risk group among children with HIV infection in a big city
Цель исследования: установить в условиях мегаполиса особенности формирования группы риска по туберкулезу у детей 0-17 лет с ВИЧ-инфекцией для планирования профилактических противотуберкулезных мероприятий. Материалы и методы. Изучены основные статистические показатели по туберкулезу, ВИЧ-инфекции и их сочетанию у детей 0-17 лет за 2009-2018 гг. Проанализированы все случаи туберкулеза, сочетанного с ВИЧ-инфекцией, впервые зарегистрированные у детей 0-17 лет на территории Москвы в 2004-2018 гг. Результаты исследования. На фоне снижения заболеваемости детей туберкулезом и ВИЧ-инфекцией в Москве за 10-летний период (2009-2018 гг.) наблюдается увеличение группы «риска развития туберкулеза в связи с ВИЧ-инфекцией» как за счет детей, рожденных женщинами с ВИЧ-инфекцией (в 1,8 раза), так и детей с подтвержденной ВИЧ-инфекцией (в 2,1 раза), что отчасти объясняется интенсивными миграционными процессами в мегаполисе. В структуре наблюдаемых контингентов детей с ВИЧ-инфекцией установлены тенденции, заключающиеся в увеличении числа и доли лиц: старше 8 лет; в стадии вторичных заболеваний и с поздними стадиями ВИЧ-инфекции; мигрантов из других регионов. В 2004-2018 гг. наиболее часто сочетание туберкулеза и ВИЧ-инфекции выявлялось среди детей 8-11 лет (14/34; 41,2%), ранее не обследованных на ВИЧ-инфекцию, и среди лиц, проживавших до выявления заболеваний не в Москве (16/34; 47,1%). Наиболее тяжелые клинические случаи сочетания туберкулеза и ВИЧ-инфекции , в том числе с летальным исходом, также наблюдались среди детей из числа мигрирующего населения, не имевших регулярного медицинского наблюдения.
- 10 March 2021
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 99 (2) , 21-28-28
Open AccessSpecific parameters for formation of the tuberculosis risk group among children with HIV infection in a big city
Цель исследования: установить в условиях мегаполиса особенности формирования группы риска по туберкулезу у детей 0-17 лет с ВИЧ-инфекцией для планирования профилактических противотуберкулезных мероприятий. Материалы и методы. Изучены основные статистические показатели по туберкулезу, ВИЧ-инфекции и их сочетанию у детей 0-17 лет за 2009-2018 гг. Проанализированы все случаи туберкулеза, сочетанного с ВИЧ-инфекцией, впервые зарегистрированные у детей 0-17 лет на территории Москвы в 2004-2018 гг. Результаты исследования. На фоне снижения заболеваемости детей туберкулезом и ВИЧ-инфекцией в Москве за 10-летний период (2009-2018 гг.) наблюдается увеличение группы «риска развития туберкулеза в связи с ВИЧ-инфекцией» как за счет детей, рожденных женщинами с ВИЧ-инфекцией (в 1,8 раза), так и детей с подтвержденной ВИЧ-инфекцией (в 2,1 раза), что отчасти объясняется интенсивными миграционными процессами в мегаполисе. В структуре наблюдаемых контингентов детей с ВИЧ-инфекцией установлены тенденции, заключающиеся в увеличении числа и доли лиц: старше 8 лет; в стадии вторичных заболеваний и с поздними стадиями ВИЧ-инфекции; мигрантов из других регионов. В 2004-2018 гг. наиболее часто сочетание туберкулеза и ВИЧ-инфекции выявлялось среди детей 8-11 лет (14/34; 41,2%), ранее не обследованных на ВИЧ-инфекцию, и среди лиц, проживавших до выявления заболеваний не в Москве (16/34; 47,1%). Наиболее тяжелые клинические случаи сочетания туберкулеза и ВИЧ-инфекции , в том числе с летальным исходом, также наблюдались среди детей из числа мигрирующего населения, не имевших регулярного медицинского наблюдения.
- Open Access
- 2 February 2021
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 99 (1) , 15-25
Efficiency of screening for tuberculosis infection in children and adolescents in Moscow in 2019 based on the new procedure for using the intradermal test with tuberculosis recombinant allergen (ESAT-6/CFP-10)
Эффективность скрининга туберкулезной инфекции у детей и подростков в г. Москве в 2019 г. на основе нового алгоритма применения внутрикожной пробы с аллергеном туберкулезным рекомбинантным (ESAT-6/CFP-10)
- 2 February 2021
- Published by LLC "Medical Knowledge and Technologies" in Tuberculosis and Lung Diseases
- Vol. 99 (1) , 15-25
Open AccessEfficiency of screening for tuberculosis infection in children and adolescents in Moscow in 2019 based on the new procedure for using the intradermal test with tuberculosis recombinant allergen (ESAT-6/CFP-10)
Эффективность скрининга туберкулезной инфекции у детей и подростков в г. Москве в 2019 г. на основе нового алгоритма применения внутрикожной пробы с аллергеном туберкулезным рекомбинантным (ESAT-6/CFP-10)
- 13 April 2020
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 99 (2)
SCREENING FOR TUBERCULOSIS INFECTION WITH VARIOUS OPTIONS FOR THE USE OF RECOMBINANT TUBERCULOSIS ALLERGEN IN CHILDREN AND ADOLESCENTS IN MOSCOW
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.
- 13 April 2020
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 99 (2)
SCREENING FOR TUBERCULOSIS INFECTION WITH VARIOUS OPTIONS FOR THE USE OF RECOMBINANT TUBERCULOSIS ALLERGEN IN CHILDREN AND ADOLESCENTS IN MOSCOW
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.